My Approach When Prescribing Here's my general framework not a rigid protocol, but a starting point for the conversation: I Tend to Start with Semaglutide When The patient has established cardiovascular disease (because of the SELECT trial data) Insurance covers semaglutide but not tirzepatide The patient has MASH/fatty liver disease Cost is the primary concern and semaglutide is more accessible I Tend to Start with Tirzepatide When Maximum weight loss is the primary goal The patient has type 2 diabetes (tirzepatide shows greater A1C reduction roughly 2.02.5% vs 1.02.0% for semaglutide) The patient has tried semaglutide with insufficient results Insurance covers both options equally Regardless of which medication we choose, I always emphasize that GLP-1 therapy is most effective when combined with nutritional counseling, physical activity, and behavioral support

For example, a single oral administration of the sheep-derived phage CEV1 was reported to reduce the abundance of Escherichia coli O157:H7 in the ovine intestine by approximately two log units within 2 days 200
One very important point: injectable B12 is primarily a medical treatment for a diagnosed deficiency
If you are exclusively breastfeeding a newborn, appetite suppression may create challenges during a time of high energy demand
So it isnt surprising that some parents consider giving their children Tylenol/Acetaminophen or Ibuprofen/Motrin/Advil preemptively
doi: 10.1371/journal.pone.0206388 240 SarkerU.ObaS